MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

T. Belal, S. Elgamal (Mansoura, Egypt)

Meeting: MDS Virtual Congress 2020

Abstract Number: 383

Keywords: Bradykinesia, Cognitive dysfunction, Parkinsonism dementia complex(PDC)

Category: Parkinson's Disease: Cognitive functions

Objective: Studying white matter changes in Parkinson’s disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment.

Background: Cognitive dysfunction is a common non-motor manifestation in PD. There were six-fold increased risk for developing cognitive impairment accompanies PD Patients with older age those with age above 60 years at disease onset, increased severity and long duration of the disease are risk factors for development of dementia in PD. Parkinson’s disease dementia is usually subcortical with altered personality, psychomotor retardation, and memory problems. Executive dysfunction is one of the most common cognitive impairment reported in PD. It is considered as an  early sign of cognitive dysfunction that involves the prefrontal cortex of the brain and the dopamine system. DTI as a novel functional MRI sequence has been applied in PD to understand the mechanisms of various clinical manifestations, it is valuable for assessing the clinical severity based on an investigation of the correlation between FA in the corpus callosum and cognitive dysfunction .DTI provides promising biomarkers for the clinical manifestations of PD.

Method: 50 patients with idiopathic Parkinson’s disease with cognitive impairment (M: F = 41:9 ; age: 62.72±9.07 years) and 20 Parkinson’s disease with normal cognition as a control (M:F =13:7 ; age 58.95±11.22) underwent cognitive testing with Mini-Mental State Examination(MMSE) and Montreal cognitive assessment, disease severity with Modified Hoehn and Yahr Scale and Unified Parkinson disease rating scale and Diffusion tensor imaging (DTI) where the corpus callosum was divided into three regions and the cingulum into two regions bilaterally to define tract. Statistical Package for the Social Sciences (SPSS) vs.21 was used for statistical analysis. A ‘p’ b 0.05 was considered as statistically significant.

Results: There were FA or MD differences between groups in both the corpus callosum and cingulum pathways. In PD with cognitive impairment subjects, the MOCA score correlated with DTI parameters of the corpus callosum and cingulum. These findings were independent of age, sex and total white matter volume.

Conclusion: Early cognitive impairment in PD patients are associated with tractography changes of the corpus callosum and cingulum.

References: Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003). Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of neurology, 60(3), 387-392. Emre, M. (2004). Dementia in Parkinson’s disease: cause and treatment. Current opinion in neurology, 17(4), 399-404. Lenfeldt N, Hansson W, Larsson A, Nyberg L, Birgander R, Forsgren L. (2013) Diffusion tensor imaging and correlations to Parkinson rating scales. J Neurol 2013;260:2823-2830. Fahn S, Elton RL and Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. Mac Millian Healthcare Information, Florham Park NJ, pp 153–163 Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004). “Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease”. Movement Disorders. 19 (9): 1020–1028. Folstein,M.F.,Folstein,S.E.andMcHugh,P.R.(1975)Mini Mental State, a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res.12,189±98 Pangman, VC; Sloan, J; Guse, L. (2000). “An Examination of Psychometric Properties of the Mini-Mental Status Examination and the Standardized Mini-Mental Status Examination: Implications for Clinical Practice”. Applied Nursing Research. 13 (4): 209–213.  Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695-699. Yu, Z., Tao, L., Qian, Z., Wu, J., Liu, H., Yu, Y., … Sun, J., (2016). Altered brain anatomical networks and disturbed connection density in brain tumor patients revealed by diffusion tensor tractography. Int. J. Comput. Assist. Radiol. Surg. 11 (11), 2007–2019. http://dx.doi.org/10.1007/s11548-015-1330-y. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain.;132: 2958–2969. 10.1093/brain/awp245 . Thais Minett . Li Su . Elijah Mak ·Guy Williams · Michael Firbank · Rachael A. Lawson · Alison J. Yarnall · Gordon W. Duncan · Adrian M. Owen · Tien K. Khoo · David J. Brook · James B. Rowe · Roger A. Barker· David Burn · John T. O’Brien (2018) . Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD Katie Wiltshire, Luis Concha ,Myrlene Gee ,Thomas Bouchard, Christian Beaulieu ,Richard Camicioli. (2015) Corpus Callosum and Cingulum Tractography in Parkinson’s Disease The Canadian journal of neurological science. Le journal canadien des sciences neurologiques · September DOI:10.1017/S0317167100010751 Beaulieu C. (2002)The basis of anisotropic water diffusion in the nervous system-a technical review .NMR Biomed .;15(7-8): 435-55. Rebecca J.Theilmann, Jason D. Reed, David D. Song, Mingxiong X. Huang, Roland R. Lee, Irene Litvan and Deborah L. Harrington.(2013). White-matter changes correlate with cognitive functioning in Parkinson’s disease DOI: 10.3389/fneur.2013.00037 · Source: PubMed Kamagata K., Tomiyama H., Motoi Y., Kano M., Abe O., Ito K., Shimoji K., Suzuki M., Hori M., Nakanishi A., Kuwatsuru R., Sasai K., Aoki S., Hattori N. (2013) Diffusional kurtosis imaging of cingulate fibers in Parkinson disease: comparison with conventional diffusion tensor imaging. Magn. Reson. Imaging. ;31(9):1501–1506. Zheng Z., Shemmassian S., Wijekoon C., Kim W., Bookheimer S.Y., Pouratian N. (2014) DTI correlates of distinct cognitive impairments in Parkinson’s disease: DTI measures of cognitive impairment in PD. Hum. Brain Mapp.;35(4):1325–1333

To cite this abstract in AMA style:

T. Belal, S. Elgamal. White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/white-matter-changes-and-early-cognitive-impairment-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/white-matter-changes-and-early-cognitive-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley